Use of pimavanserin in the treatment of parkinson and symptoms thereof

Details for Australian Patent Application No. 2008254669 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Davis, Robert E.; Mayall, Eve Taylor; Tolf, Bo-Ragnar; Williams, Hilde; Schlienger, Nathalie; Vanover, Kimberly E.; Van Kammen, Daniel P.; Weiner, David M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008254669

PCT Pub. Number WO2008/144665

Priority 60/938,985 18.05.07 US; 60/942,990 08.06.07 US

Filing date 19 May 2008

Wipo publication date 27 November 2008

International Classifications

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/144665 Priority application(s): WO2008/144665

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254676-An improved LED device for wide beam generation and method of making the same

2008254666-Sustainable design decision support system